148 related articles for article (PubMed ID: 8034505)
1. Use of the new quinolones in pediatrics.
Schaad UB
Isr J Med Sci; 1994; 30(5-6):463-8. PubMed ID: 8034505
[TBL] [Abstract][Full Text] [Related]
2. Use of the quinolones in paediatrics.
Schaad UB
Drugs; 1993; 45 Suppl 3():37-41. PubMed ID: 7689449
[TBL] [Abstract][Full Text] [Related]
3. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
Sendzik J; Lode H; Stahlmann R
Int J Antimicrob Agents; 2009 Mar; 33(3):194-200. PubMed ID: 18835137
[TBL] [Abstract][Full Text] [Related]
4. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
[TBL] [Abstract][Full Text] [Related]
5. Systemic quinolone antibiotics in children: a review of the use and safety.
Grady RW
Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
[TBL] [Abstract][Full Text] [Related]
6. Use of quinolones in pediatrics.
Schaad UB
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):355-60. PubMed ID: 1864297
[TBL] [Abstract][Full Text] [Related]
7. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB
Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847
[TBL] [Abstract][Full Text] [Related]
8. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P
Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).
Naccari F; Salpietro DC; De Sarro A; Masaracchio A; Barberi I
Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):187-92. PubMed ID: 9583092
[TBL] [Abstract][Full Text] [Related]
10. Use of the quinolones in treatment of severe bacterial infections in premature infants.
Wlazłowski J; Krzyzańska-Oberbek A; Sikora JP; Chlebna-Sokół D
Acta Pol Pharm; 2000 Nov; 57 Suppl():28-31. PubMed ID: 11293256
[TBL] [Abstract][Full Text] [Related]
11. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
Linseman DA; Hampton LA; Branstetter DG
Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
Moffett BS; Rosenstein BJ; Mogayzel PJ
J Cyst Fibros; 2003 Sep; 2(3):152-4. PubMed ID: 15463865
[TBL] [Abstract][Full Text] [Related]
14. Quinolone-induced arthropathy in immature Equidae.
Specht TE; Frederick G
J Am Vet Med Assoc; 1991 Feb; 198(4):516. PubMed ID: 2019522
[No Abstract] [Full Text] [Related]
15. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.
Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R
J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112
[TBL] [Abstract][Full Text] [Related]
16. Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicity.
Stahlmann R
Arch Toxicol; 2003 Jan; 77(1):7-11. PubMed ID: 12491034
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
[TBL] [Abstract][Full Text] [Related]
18. The quinolone antibiotics.
Saravanos K; Duff P
Obstet Gynecol Clin North Am; 1992 Sep; 19(3):529-37. PubMed ID: 1436930
[TBL] [Abstract][Full Text] [Related]
19. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
Warren RW
Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period.
von Keutz E; Rühl-Fehlert C; Drommer W; Rosenbruch M
Arch Toxicol; 2004 Jul; 78(7):418-24. PubMed ID: 15014927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
